Improving the regulatory review of drugs and devices: Drugs - Special Access to Drugs and Health Products
Description
The Special Access Programme (SAP) provides access to nonmarketed drugs for practitioners treating patients with serious or life-threatening conditions when conventional therapies have failed, are unsuitable, or unavailable. The SAP authorizes a manufacturer to sell a drug that cannot otherwise be sold or distributed in Canada.
Resources
| Name |
Format |
Description |
Link |
| Improving the regulatory review of drugs and devices: Drugs - Special Access to Drugs and Health Products |
HTML |
|
https://www.canada.ca/en/health-canada/services/drugs-health-products/special-access/drugs.html |
| Improving the regulatory review of drugs and devices: Drugs - Special Access to Drugs and Health Products |
HTML |
|
https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/acces-special/medicaments.html |